Sionna Therapeutics Inc.

NASDAQ: SION · Real-Time Price · USD
20.89
-0.02 (-0.10%)
At close: Aug 15, 2025, 3:59 PM
20.82
-0.34%
After-hours: Aug 15, 2025, 04:04 PM EDT

Sionna Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q2 2024 Q1 2024 Q4 2023
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023
Net Income
-18.07M -16.48M -15.85M -8.55M -11.85M -11.88M
Depreciation & Amortization
-2.02M 159K 167K 166K 166K 161K
Stock-Based Compensation
2.84M 2.09M 1.06M n/a 647K 572K
Other Working Capital
1.43M -5.41M 2.05M -1.59M -4.19M 2.89M
Other Non-Cash Items
1.49M -206K -300K 358K 381K 572K
Deferred Income Tax
n/a n/a n/a n/a n/a n/a
Change in Working Capital
-2.4M -1.85M 3.14M -2.12M -2.52M 3.12M
Operating Cash Flow
-18.15M -16.29M -11.78M -10.14M -13.18M -7.45M
Capital Expenditures
n/a -86K n/a n/a n/a -122K
Cash Acquisitions
n/a n/a n/a n/a n/a n/a
Purchase of Investments
-56.42M -171.59M -7.2M -28.62M -123.93M n/a
Sales Maturities Of Investments
33.17M 30.49M 22.45M n/a n/a 7.25M
Other Investing Acitivies
n/a n/a n/a n/a n/a n/a
Investing Cash Flow
-23.25M -141.19M 15.23M -28.62M -123.93M 7.13M
Debt Repayment
n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
n/a n/a -1.41M n/a 5K n/a
Financial Cash Flow
-312K 202.39M -1.41M 38K 181.33M n/a
Net Cash Flow
-41.71M 44.91M 2.04M n/a 44.23M -324K
Free Cash Flow
-18.15M -16.37M -11.81M -10.14M -13.18M -7.57M